Objectives & Milestones

Objectives:

MISSION: To continuously provide the highest quality pharmaceutical products, clinical direction and research material to the medical fraternity that will enhance the quality of life worldwide.

VISION: To be a global player in healthcare and pharmaceuticals providing a cost-effective solution to disease treatment and prophylaxis.

 

History & Milestones:

1977 ENTOD PHARMACEUTICALS LTD (INDIA) incorporated as a company and started MARKETING exclusive OPHTHALMIC and ENT ranges manufactured at reputed third parties.
1980 Set up its first manufacturing plant at MIDC, Rabale (Maharashtra, India) for manufacturing Sterile Dosage Forms.
1983 The first company to launch Hypromellose Eye Drops in India as “LACRYL EYE DROPS”.
1985 Set up its second manufacturing plant at MIDC, Ambernath (Maharashtra, India) for manufacturing Tablets, Liquids and Capsules dosage forms.
1986 Expansion of Rabale manufacturing plant allowing manufacturing for various reputed companies such as M/s. Crossland, M/s. Indo Pharma.
1990 Started it’s own marketing of Ophthalmic and ENT brands with 50 Medical representatives in different parts of India.
1992 Set up its own formulation R & D at Rabale.
1992-1995 Contract manufacturing for various Pharma Companies specialized in OPHTHALMIC & ENT Medicines.
1996 Established full fledged marketing department and expanded its Field Force to 100 Medical Representatives.
2000 The first company to launch Erythromycin Eye Ointment USP as “OPTITHROCIN”.
2001 The first Indian company to launch a unique combination of Flurbiprofen and Chloramphenicol as “FLUBICHLOR”.
2003 The first company to manufacture IN-HOUSE OXYCHLORO COMPLEX as PRESERVATIVE for Opthalmic drops in India
2005 The first India company to launch Timolol Maleate with Oxychloro Complex and HPMC as “TIMOL-P”
2008 The first India company to launch a unique combination of Gatifloxacin with Flurbiprofen with Neutral pH as “FLUBIGAT” – a great success for its formulation R & D.
2009 Modernization of Rabale Formulation R&D resulting in a state-of-the-art facility
2009 Incorporation of ENTOD RESEARCH CELL UK Ltd. (ERC) in London to provide Research Support to ENTOD PHARMACEUTICALS LTD. (INDIA)
2010 Launch of Entod´s “Prevent Blindness” programme to raise the awareness of Glaucoma and other Preventable Blindness in India
2010 Patent applied for Ophthalmic Buffer Technology by ERC (UK)
2011 Modernization of ERC facilities to include a brand new GLP accredited Laboratory and Formulation Research Centre in London (UK) and Glasgow (UK)
2011 Patent Applications for various Ophthalmic Formulation Technologies such as Liposorb, LycoHance and PolyVisc from ERC (UK) and Entod Pharmaceuticals Ltd. (INDIA)
2012 Collaboration of ENTOD PHARMACEUTICALS LTD. (INDIA) and ENTOD RESEARCH CELL UK Ltd. (UK) to form the ENTOD INTERNATIONAL Group